MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 2 filers reported holding MACROGENICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,691,090 | -14.2% | 1,221,245 | -1.5% | 0.00% | 0.0% |
| Q2 2023 | $6,630,149 | -13.3% | 1,239,315 | +16.2% | 0.00% | -33.3% |
| Q1 2023 | $7,645,327 | +150665.7% | 1,066,303 | +41.1% | 0.00% | +200.0% |
| Q4 2022 | $5,071 | -99.7% | 755,824 | +60.8% | 0.00% | 0.0% |
| Q3 2022 | $1,627,000 | -39.8% | 470,093 | -48.7% | 0.00% | 0.0% |
| Q2 2022 | $2,701,000 | -73.6% | 915,894 | -21.1% | 0.00% | -66.7% |
| Q1 2022 | $10,223,000 | -48.5% | 1,160,352 | -6.1% | 0.00% | -50.0% |
| Q4 2021 | $19,836,000 | -22.2% | 1,235,876 | +1.5% | 0.01% | -25.0% |
| Q3 2021 | $25,485,000 | -25.8% | 1,217,084 | -4.8% | 0.01% | -27.3% |
| Q2 2021 | $34,335,000 | -3.1% | 1,278,304 | +14.9% | 0.01% | -8.3% |
| Q1 2021 | $35,423,000 | +26.5% | 1,112,233 | -9.2% | 0.01% | +20.0% |
| Q4 2020 | $28,002,000 | -18.3% | 1,224,848 | -10.0% | 0.01% | -33.3% |
| Q3 2020 | $34,278,000 | -10.2% | 1,360,785 | -0.5% | 0.02% | -11.8% |
| Q2 2020 | $38,176,000 | +382.8% | 1,367,326 | +0.6% | 0.02% | +325.0% |
| Q1 2020 | $7,907,000 | -44.3% | 1,358,595 | +4.1% | 0.00% | -20.0% |
| Q4 2019 | $14,195,000 | -14.0% | 1,304,737 | +0.8% | 0.01% | -16.7% |
| Q3 2019 | $16,513,000 | -22.9% | 1,294,160 | +2.5% | 0.01% | -25.0% |
| Q2 2019 | $21,425,000 | +5.1% | 1,262,543 | +11.4% | 0.01% | 0.0% |
| Q1 2019 | $20,384,000 | +98.6% | 1,133,757 | +40.3% | 0.01% | +60.0% |
| Q4 2018 | $10,264,000 | -17.8% | 808,201 | +38.7% | 0.01% | 0.0% |
| Q3 2018 | $12,489,000 | +109.3% | 582,511 | +101.6% | 0.01% | +150.0% |
| Q2 2018 | $5,968,000 | -18.1% | 288,984 | -0.2% | 0.00% | -33.3% |
| Q1 2018 | $7,283,000 | +32.4% | 289,484 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $5,500,000 | +5.0% | 289,484 | +2.1% | 0.00% | 0.0% |
| Q3 2017 | $5,239,000 | +65.5% | 283,517 | +56.9% | 0.00% | +100.0% |
| Q2 2017 | $3,165,000 | +290.7% | 180,739 | +314.8% | 0.00% | – |
| Q1 2017 | $810,000 | – | 43,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 707,978 | $21,176,000 | 2.34% |
| Opaleye Management Inc. | 145,000 | $4,337,000 | 2.27% |
| TIGER MANAGEMENT L.L.C. | 266,067 | $7,958,000 | 1.88% |
| TANAKA CAPITAL MANAGEMENT INC | 26,170 | $783,000 | 1.88% |
| BB BIOTECH AG | 1,455,000 | $43,519,000 | 1.53% |
| Eventide Asset Management | 725,800 | $21,709,000 | 1.32% |
| DAFNA Capital Management LLC | 54,200 | $1,621,000 | 1.13% |
| Spark Investment Management LLC | 390,600 | $11,682,000 | 0.95% |
| Private Capital Advisors, Inc. | 72,500 | $2,168,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 140,000 | $4,187,400,000 | 0.66% |